Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, June 02, 2009

Sunesis Pharmaceuticals: Phase 2 Study of Single Agent Voreloxin in Women with Platinum-Resistant Ovarian Cancer

http://tinyurl.com/ojgmrx

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.